GlaxoSmithKline Contracts

Sample Business Contracts from GlaxoSmithKline

Agreement for the Sale and Purchase of a Portfolio of Pharmaceutical, OTC and Consumer Healthcare Products - SmithKline Beechan plc and ICN Pharmaceuticals Inc. (Feb 24, 1998)
Asset Purchase Agreement - Biovail Laboratories International SRL and GlaxoSmithKline LLC (Feb 2, 2011)
Asset Purchase Agreement - Biovail Laboratories International SRL and SmithKline Beecham Corp. d/b/a GlaxoSmithKline (May 5, 2009)
Asset Purchase Agreement - SmithKline Beecham Clinical Laboratories Inc. and Healtheon Corp. (Dec 31, 1998)
Asset Sale Agreement - Diversa Corp. and Glaxo Wellcome SA (Jul 18, 2003)
Assets Purchase Agreement - SmithKline Beecham Clinical Laboratories Inc. and ActaMed Corp. (Dec 31, 1997)
Collaboration Agreement - Glaxo Research and Development Ltd., Glaxo Group Ltd. and Diversa Corp. (Dec 8, 2000)
Collaboration Agreement and License Agreement [Amendment] - SmithKline Beecham Corp., SmithKline Beecham plc and Human Genome Sciences Inc. (Jun 28, 1996)
Collaboration and License Agreement - SmithKline Beecham Corp., SmithKline Beecham plc, Human Genome Sciences Inc. and Merck KGaA (Jul 10, 1996)
Collaboration and License Agreement - SmithKline Beecham Corp., SmithKline Beecham plc, Human Genome Sciences Inc. and Synthelabo (Jun 30, 1996)
Development Agreement - SmithKline Beecham Clinical Laboratories Inc. and ActaMed Corp. (Oct 31, 1997)
Development and License Agreement - Protein Design Labs Inc. and SmithKline Beecham Corp. (Sep 28, 1999)
Distribution and Supply Agreement - Smithkline Beecham Corp. d/b/a GlaxoSmithKline and Celgene Corp (Mar 31, 2003)
Distribution Rights Agreement - SmithKline Beecham Corp. and Biovail Laboratories Inc. (Jan 2004)
Distribution Rights Agreement [Amendment No. 2] - Biovail Laboratories International SRL and SmithKline Beecham Corp. (Oct 12, 2005)
Distribution Rights Agreement [Amendment No. 3] - Biovail Laboratories International SRL and SmithKline Beecham Corp. (Dec 18, 2006)
Distribution Rights Agreement [Amendment No. 4] - Biovail Laboratories International SRL and SmithKline Beecham Corp. (Nov 21, 2008)
Distribution Rights Agreement [Amendment No. 5] - Biovail Laboratories International SRL and SmithKline Beecham Corp. (May 14, 2009)
Distribution Rights Agreement [Amendment No. 6] - Biovail Laboratories International SRL and SmithKline Beecham Corp. (Sep 16, 2009)
Distribution Rights Agreement [Amendment No. 7] - Biovail Laboratories International SRL and SmithKline Beecham Corp. (Nov 2009)
Distribution Rights Agreement [Amendment] - Biovail Laboratories International SRL and SmithKline Beecham Corp. (May 1, 2005)
Leptin Research, Development and License Agreement - SmithKline Beecham plc and Ligand Pharmaceuticals Inc. (Mar 17, 1998)
License Agreement - GlaxoSmithKline and Andrx Pharmaceuticals LLC (Feb 9, 2007)
License Agreement - SmithKline Beecham Clinical Laboratories Inc. and ActaMed Corp. (Dec 31, 1997)
License Agreement - SmithKline Beecham Corp., SmithKline Beecham plc and Human Genome Sciences Inc. (Jun 28, 1996)
License and Collaboration Agreement [Amendment No. 1] - Valeant Pharmaceuticals North America and Glaxo Group Ltd. (Feb 10, 2009)
Non-Exclusive License Agreement - ViaCell Inc. and SmithKline Beecham Corp. d/b/a GlaxoSmithKline (Jan 1, 2003)
Patent License Agreement [IL-5] - Protein Design Labs Inc. and SmithKline Beecham Corp. (Sep 28, 1999)
Patent Rights Agreement - Protein Design Labs Inc. and SmithKline Beecham Corp. (Sep 28, 1999)
Registration Rights Agreement - Maxygen Inc. (Nov 13, 2000)
Research Collaboration and License Agreement - Sequenom Inc., Glaxo Group Ltd. and SmithKline Beecham Corp. (Aug 23, 2001)
Research Collaboration and License Agreement - SmithKline Beecham plc and MedImmune Inc. (Dec 10, 1997)
Services Agreement - ActaMed Corp. and SmithKline Beecham Clinical Laboratories Inc. (Dec 31, 1997)
Services Agreement - Healtheon Corp. and SmithKline Beecham Clinical Laboratories Inc. (Jan 19, 1999)
Stock Purchase Agreement [Series E Preferred] - Ciphergen Biosystems Inc. (Mar 3, 2000)
Technology Transfer Agreement - Affymax Technologies NV, Glaxo Group Ltd. and Maxygen Inc. (Feb 1, 1997)
Therapeutic Collaboration and License Agreement - Human Genome Sciences Inc., Schering Corp., Schering Plough Ltd., SmithKline Beecham Corp. and SmithKline Beecham plc (Jun 28, 1996)
Trademark and Domain Name License Agreement - GlaxoSmithKline LLC and Biovail Laboratories International SRL
Trademark License Agreement - SmithKline Beecham Corp. and Biovail Laboratories International SRL (May 14, 2009)